DBOCX
Price
$25.38
Change
+$0.10 (+0.40%)
Updated
Sep 26 closing price
Net Assets
286.54M
RLBAX
Price
$38.14
Change
+$0.10 (+0.26%)
Updated
Sep 26 closing price
Net Assets
262.04B
Interact to see
Advertisement

DBOCX vs RLBAX

Header iconDBOCX vs RLBAX Comparison
Open Charts DBOCX vs RLBAXBanner chart's image
BNY Mellon Balanced Opportunity C
Price$25.38
Change+$0.10 (+0.40%)
VolumeN/A
Net Assets286.54M
American Funds American Balanced R1
Price$38.14
Change+$0.10 (+0.26%)
VolumeN/A
Net Assets262.04B
DBOCX vs RLBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DBOCX vs. RLBAX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBOCX is a Hold and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 262B vs. DBOCX (287M). RLBAX pays higher dividends than DBOCX: RLBAX (1.15) vs DBOCX (0.40). DBOCX was incepted earlier than RLBAX: DBOCX (22 years) vs RLBAX (23 years). DBOCX (2.03) is less costly to investors than RLBAX (1.31). DBOCX (46.25) and RLBAX (44.00) have comparable annual turnover. RLBAX has a lower initial minimum investment than DBOCX: RLBAX (250) vs DBOCX (1000). RLBAX annual gain was more profitable for investors over the last year : 7.27 vs. DBOCX (3.07). RLBAX return over 5 years is better than : 40.00 vs. DBOCX (11.82).
DBOCXRLBAXDBOCX / RLBAX
Total Expense Ratio1.901.31145%
Annual Report Gross Expense Ratio2.031.31155%
Fund Existence22 years23 years-
Gain YTD8.17312.53165%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets287M262B0%
Annual Yield % from dividends0.401.1535%
Returns for 1 year3.077.2742%
Returns for 3 years31.5748.1966%
Returns for 5 years11.8240.0030%
Returns for 10 years28.9874.5139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WWD249.095.13
+2.10%
Woodward
PTHS33.800.56
+1.68%
Pelthos Therapeutics Inc
ENTO4.750.04
+0.85%
Entero Therapeutics Inc
MQ5.360.01
+0.19%
Marqeta
CASS40.39-0.13
-0.32%
Cass Information Systems